That sounds like a very good integrated work flow. Easy to use for the consumer and doctor and pretty much guaranteeing its use in the correct scenario. This is a million times better than the solutions implemented by the Australian telehealth providers.
The doctor saying you have 'nothing special' is great news for you, much better than 'you likely have pneumonia and we better get you off to hospital'.
- Forums
- ASX - By Stock
- RAP
- Ann: Medgate extends European ResAppDx trial
Ann: Medgate extends European ResAppDx trial, page-39
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online